risperidone has been researched along with Adenocarcinoma in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The absorption rate constant was lower in the verapamil group." | 1.34 | P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model. ( Barthélémy, C; Brossard, D; Clavey, V; Cousein, E; Crauste-Manciet, S; Danel, C; Joiris, E; Lestavel, S; Odou, P; Poullain, S; Robert, H; Simon, N; Vaccher, C; Williame, V, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilly, SJ | 1 |
| Clark, AJ | 1 |
| Marsh, A | 1 |
| Mitchell, DA | 1 |
| Cain, R | 1 |
| Fishwick, CWG | 1 |
| Taylor, PC | 1 |
| Cousein, E | 1 |
| Barthélémy, C | 1 |
| Poullain, S | 1 |
| Simon, N | 1 |
| Lestavel, S | 1 |
| Williame, V | 1 |
| Joiris, E | 1 |
| Danel, C | 1 |
| Clavey, V | 1 |
| Brossard, D | 1 |
| Robert, H | 1 |
| Crauste-Manciet, S | 1 |
| Vaccher, C | 1 |
| Odou, P | 1 |
2 other studies available for risperidone and Adenocarcinoma
| Article | Year |
|---|---|
A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxyacyl CoA Dehydrogenases; Adenocarcinoma; Animals; Antineo | 2017 |
P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model.
Topics: Adenocarcinoma; Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Trans | 2007 |